BostonGene to Present at the 2023 San Antonio Breast Cancer Symposium
BostonGene , a leading provider of AI-driven, molecular and immune profiling solutions, today announced that two abstracts have been accepted for poster presentations for the 2023 San Antonio Breast Cancer Symposium (SABCS), which will be held December 5 - 9, 2023, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
- BostonGene , a leading provider of AI-driven, molecular and immune profiling solutions, today announced that two abstracts have been accepted for poster presentations for the 2023 San Antonio Breast Cancer Symposium (SABCS), which will be held December 5 - 9, 2023, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
- "We are excited to present our research at the 2023 San Antonio Breast Cancer Symposium, showcasing our commitment to improving breast cancer treatment through innovative molecular profiling.
- By developing novel approaches to transcriptomic classification, we aim to revolutionize the way we understand and treat breast cancer," said Nathan Fowler, MD, Chief Medical Officer at BostonGene.
- For more information, please visit the 2023 San Antonio Breast Cancer Symposium website .